While THC, CBD, and CBG are all major cannabis plant types, many are unaware that CBGa also has its cultivars; these four are the most abundant cannabinoids in cannabis. There are now well over 100 known cannabinoids in the plant identified and many in small amounts. Since cannabinoids are a class of terpenoids, some believe the plant may have 1,000 different constituents.
__
Chemists can convert CBD into them and create a stable replica in semi-synthetics; Delta-8-THC and even the most known THC, Delta 9,would all be good examples. Some examples of minor cannabinoids include cannabichromene (CBC), cannabinol (CBN), tetrahydrocannabivarin (THCV), cannabidivarin (CBDV), and many others.
__
Cannabielsoinic acid (CBEA) is a minor cannabinoid believed to be a precursor to other cannabinoids in the cannabis plant. It is a carboxylic acid form, meaning it is the acidic form of the cannabinoid before it undergoes decarboxylation to become its neutral counterpart. Once this occurs, we have the Cannabinoid CBE.
The intrigue surrounding CBEA-A stems from its functional units' complex chemical makeup and arrangement. While thorough investigations into this interesting Cannabinoid, created by the precursor CBGVa, and similar compounds are still in the early stages, the prospects are promising.__
Researchers are exploring the untapped potential of cannabinoids far beyond any psychoactive therapeutic capabilities, with high hopes that CBEA-A could be a significant breakthrough in this quest.
__
Cannabielsoin (CBE) is another minor cannabinoid that is derived from CBEA-A. CBE is structurally related to other cannabinoids but may have unique properties and potential therapeutic effects.
__
Each minor cannabinoid has its unique chemical structure and potential effects on the body's endocannabinoid system (ECS). Early research suggests these minor cannabinoids may have various therapeutic benefits and can help increase the productivity of the Endocannabinoid system.
__
No studies, or very limited, are available on many of the minors. One thing we do know about endocannabinoids is their vast abilities to perform inside our body, helping us with many issues. It's thought by many that endocannabinoids and minor cannabinoids interact to produce synergistic effects.
The exploration and study of minor cannabinoids are ongoing, and researchers are trying to understand their specific effects and potential applications in the future treatment of conditions such as chronic pain, epilepsy, inflammation, neurodegenerative diseases, and mental health disorders.
_
However, it's important to note that more research is needed to uncover the therapeutic potential of minor cannabinoids fully and to establish optimal dosages and delivery methods for their use._
While our plant is still jailed as a Schedule I substance on the federal level, pharmaceutical, and biotechnology companies are toying with various synthetic creations of minor cannabinoids but, for the most part, haven't produced anything to get excited about - what's new?
__
Many are hopeful that legalization will allow them to grow Cannabis in their gardens, as many once did hundreds of years ago. For now, we learn as much as we can about cannabinoids from the plant and our body's - endocannabinoids.
-Mike Robinson, Co Founder, CBGa Crumble, and the Creator of ECS Balance Control
.